Stock AnalizCME Group (CME) earnings for the quarter ended September 2026: EPS beats estimates
CME Group reported results for the quarter ended September 2026 on October 21, 2026. Adjusted earnings per share came in at $3.02 against the analysts’ average forecast of $2.99, a beat of 1.0%.
Revenue for the quarter was $1.74 billion, up 13.0% from $1.54 billion in the same quarter a year earlier.
The market’s verdict: the stock rose 0.2% on the first trading day after the report.
The last four quarters
CME Group has beaten the analysts’ EPS forecast in 3 of the last 4 quarters.
| Quarter | EPS | Forecast | Surprise | Revenue growth | Price reaction |
|---|---|---|---|---|---|
| Sep 2026 | $3.02 | $2.99 | +1.0% | +13% | +0.2% |
| Jun 2026 | $2.99 | $2.91 | +2.8% | +1% | +7.1% |
| Mar 2026 | $3.36 | $3.37 | −0.2% | +14% | +0.4% |
| Dec 2025 | $2.77 | $2.74 | +1.0% | +8% | +1.5% |
What comes next
Analysts expect EPS of $3.03 for the next quarter on average and $12.40 for the fiscal year ending December 31, 2026.
The average analyst price target is $317.06, 0% below the current price of $317.97.
Valuation and score
CME Group scores 2.4 out of 5 overall on Stock Analiz (average), trades at a trailing P/E of about 26.1, and its intrinsic value under moderate assumptions is about 41% below the current market value. Full CME Group analysis with 10 years of financials
Frequently asked questions
What was CME Group’s EPS for the quarter ended September 2026?
$3.02 adjusted per share, against an analyst consensus of $2.99.
How much revenue did CME Group report?
$1.74 billion, up 13.0% year over year.
More
This report was written automatically from the published numbers within hours of the release. It is information, not investment advice.